PAPER Wittwer M, Grandgirard D, Rohrbach J, Leib SL
SEARCH RESULTS
255975 RESULTS
Sort By:
- Journal Title
- First Author
- Publication Date
- Most Commented
PAPER Yakubu MA, Nsaif RH, Oyekan AO
Regulation of cerebrovascular endothelial peroxisome proliferator activator receptor alpha expression and nitric oxide production by clofibrate.
Bratisl Lek Listy. 2010;111(5):258-64. PubMed: 20568414PAPER Fox JH, Connor T, Chopra V, Dorsey K, Kama JA, Bleckmann D, Betschart C, Hoyer D, Frentzel S, Difiglia M, Paganetti P, Hersch SM
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease.
Mol Neurodegener. 2010;5:26. PubMed: 20569486PAPER Mattsson N, Bremell D, Anckarsäter R, Blennow K, Anckarsäter H, Zetterberg H, Hagberg L
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism.
BMC Neurol. 2010;10:51. PubMed: 20569437PAPER Hu JL, Liu G, Li YC, Gao WJ, Huang YQ
Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons.
Mol Brain. 2010;3:20. PubMed: 20569495PAPER De Cegli R, Romito A, Iacobacci S, Mao L, Lauria M, Fedele AO, Klose J, Borel C, Descombes P, Antonarakis SE, di Bernardo D, Banfi S, Ballabio A, Cobellis G
A mouse embryonic stem cell bank for inducible overexpression of human chromosome 21 genes.
Genome Biol. 2010;11(6):R64. PubMed: 20569505PAPER Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, Solfrizzi V
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms.
J Alzheimers Dis. 2010;21(3):691-724. PubMed: 20571214PAPER Amadoro G, Corsetti V, Stringaro A, Colone M, D'Aguanno S, Meli G, Ciotti M, Sancesario G, Cattaneo A, Bussani R, Mercanti D, Calissano P
A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
J Alzheimers Dis. 2010;21(2):445-70. PubMed: 20571215PAPER Güntert A, Campbell J, Saleem M, O'Brien DP, Thompson AJ, Byers HL, Ward MA, Lovestone S
Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease.
J Alzheimers Dis. 2010;21(2):585-96. PubMed: 20571216PAPER Rodríguez-Rodríguez E, Vázquez-Higuera JL, Sánchez-Juan P, Mateo I, Pozueta A, Martínez-García A, Frank A, Valdivieso F, Berciano J, Bullido MJ, Combarros O
Epistasis between intracellular cholesterol trafficking-related genes (NPC1 and ABCA1) and Alzheimer's disease risk.
J Alzheimers Dis. 2010;21(2):619-25. PubMed: 20571217PAPER Arrieta-Cruz I, Wang J, Pavlides C, Pasinetti GM
Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease.
J Alzheimers Dis. 2010;21(2):649-54. PubMed: 20571219PAPER Eriksson UK, Sjöberg BG, Bennet AM, de Faire U, Pedersen NL, Frostegård J
Low levels of antibodies against phosphorylcholine in Alzheimer's disease.
J Alzheimers Dis. 2010;21(2):577-84. PubMed: 20571218PAPER Liu SJ, Gasperini R, Foa L, Small DH
Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2.
J Alzheimers Dis. 2010;21(2):655-66. PubMed: 20571220PAPER Wang H, Ma J, Tan Y, Wang Z, Sheng C, Chen S, Ding J
Amyloid-beta1-42 induces reactive oxygen species-mediated autophagic cell death in U87 and SH-SY5Y cells.
J Alzheimers Dis. 2010;21(2):597-610. PubMed: 20571221PAPER Sinning M, van Rooyen JP, Venegas-Francke P, Vásquez C, Behrens MI, Ramírez A
Clinical and genetic analysis of a Chilean family with early-onset autosomal dominant Alzheimer's disease.
J Alzheimers Dis. 2010;21(3):757-61. PubMed: 20571222Current Filters
- TYPE: Paper x